Agenda is subject to change.

OMS 2025 is supported by unrestricted educational grants from Astellas, Regeneron Pharmaceuticals, Inc. and Sun Pharmaceuticals. In addition, individual sessions are supported by Amgen and Gentex.

CE Co-Sponsored By: